C. Joseph Ross Daval, JD; Theodore W. Teng; Massimiliano Russo, PhD; et al.
open access
has audio
JAMA Health Forum. 2023;4(7):e231718. doi:10.1001/jamahealthforum.2023.1718
This quality improvement study assesses the frequency, purposes, and voting outcomes of US Food and Drug Administration (FDA) human drug advisory committee meetings from 2010 to 2021 and how often the FDA acted in accordance with committee recommendations.
-
Podcast:
FDA Advisory Committees for New Prescription Drugs
Linda H. Aiken, PhD, RN; Karen B. Lasater, PhD, RN; Douglas M. Sloane, PhD; et al.
open access
JAMA Health Forum. 2023;4(7):e231809. doi:10.1001/jamahealthforum.2023.1809
This cross-sectional survey study explores physician and nurse burnout, intent to leave, turnover, mental health, work-life balance, patient safety, and preferences for interventions at 60 US hospitals.
Edward W. Zhou, PharmD; Matthew J. Jackson, PhD; Fred D. Ledley, MD
open access
JAMA Health Forum. 2023;4(7):e231921. doi:10.1001/jamahealthforum.2023.1921
This cross-sectional study uses publicly available publications to compare National Institutes of Health with industry spending on phased clinical development of approved drugs.
Risha Gidwani, DrPH; Cheryl L. Damberg, PhD
open access
JAMA Health Forum. 2023;4(7):e231928. doi:10.1001/jamahealthforum.2023.1928
This cohort study of US hospitals evaluates the changes in hospital financial performance before and during the COVID-19 public health emergency.
Rebecca A. Bromley-Dulfano, MS; Maya Rossin-Slater, PhD; M. Kate Bundorf, PhD, MPH, MBA
open access
JAMA Health Forum. 2023;4(7):e231974. doi:10.1001/jamahealthforum.2023.1974
This cross-sectional study examines the association between the number of guideline-recommended screenings for cervical cancer and the risk of preterm delivery in females aged 18 to 24 years.
Christopher M. Jones, PharmD, DrPH, MPH; Yngvild Olsen, MD, MPH; Mir M. Ali, PhD; et al.
open access
JAMA Health Forum. 2023;4(7):e231982. doi:10.1001/jamahealthforum.2023.1982
This survey study compares characteristics and buprenorphine prescribing patterns for opioid use disorder (OUD) among clinicians before and after the release of new practice guidelines.
Jung Ho Gong, AB; Kenton J. Johnston, PhD; David J. Meyers, PhD
open access
JAMA Health Forum. 2023;4(7):e231991. doi:10.1001/jamahealthforum.2023.1991
This cross-sectional study examines the association of physicians caring for patients with higher levels of social and clinical risks in traditional Medicare with the likelihood of inclusion in Medicare Advantage plan networks.
Megan A. Cohen, MD, MPH; Emily R. Boniface, MPH; Megan Skye, MPH; et al.
open access
JAMA Health Forum. 2023;4(7):e232144. doi:10.1001/jamahealthforum.2023.2144
This cohort study investigates whether state funding for comprehensive reproductive health care is associated with an improvement in use of moderately and highly effective contraceptive methods among Latina women.
Arthur Robin Williams, MD, MBE; Christopher Rowe, PhD; Ryan Gallagher, MD; et al.
open access
JAMA Health Forum. 2023;4(7):e232247. doi:10.1001/jamahealthforum.2023.2247
This cohort study investigates the administration patterns and results of urine drug screening to assess its feasibility and patient outcomes in a telehealth-based opioid treatment setting.